Biotech

All Articles

Boundless Biography helps make 'moderate' layoffs five months after $100M IPO

.Merely five months after safeguarding a $100 thousand IPO, Limitless Bio is already laying off some...

Halda's $126M will definitely advance 'keep and also eliminate' tumor medications

.The initial stages of oncology R&ampD aren't except fascinating brand-new methods, and Halda Rehabs...

Lykos 'disappointments' not revealing study infractions with publisher

.Psychopharmacology has actually pulled 3 short articles about midstage medical test records determi...

Analysts examine Avidity's DMD gain, revealing subtleties in data

.Avidity Biosciences satisfied financiers with stage 1/2 records in Duchenne muscle dystrophy (DMD) ...

Actinogen's cortisol blocker falls short phase 2 anxiety study

.Actinogen Medical's cortisol blocker has skipped the major endpoint of a stage 2 research study in ...

Bivictrix makes a decision going personal only technique to take ADC right into center

.Antibody-drug conjugates (ADCs) have been at the facility of several a billion-dollar biobuck licen...

TPG bests up funds to $580M for expenditures throughout life scientific researches

.Resource supervisor TPG, which has actually supported biotechs like Sionna Therapies as well as San...

Merck ceases period 3 TIGIT test in lung cancer for futility

.Merck &amp Co.'s TIGIT plan has actually endured an additional setback. Months after shuttering a p...

After a challenging year, Exscientia folds up in to Recursion

.After a year determined through pipe hairstyles, the departure of its own CEO and also discharges, ...

Cullinan, after $25M package, return bispecific to Harbour

.Cullinan Therapy was thrilled enough with Port BioMed's bispecific immune activator that it surrend...